Retinoic acid affects basic cellular processes and SOX2 and SOX18 expression in breast carcinoma cells

نویسندگان

چکیده

Genetic and molecular heterogeneity, together with intrinsic acquired resistance to therapy, represent the major obstacles successful treatment of different types breast carcinoma. Increasing evidence demonstrates that SOX transcription factors in carcinomas could act both as oncogenes tumor suppressors have been associated stage grade, poor prognosis, therapy resistance. Both SOX2 SOX18 overexpression has correlated prognosis carcinomas, these genes are recognized potential antitumor targets. Our aim was evaluate effect retinoic acid (RA), a well-known cyto-differentiating agent, on carcinoma cells vitro investigate RA modify expression genes. By applying various experimental approaches, we evaluated basic cellular processes SK-BR-3 MCF7 cell lines. We shown inhibits growth, reduces number Ki-67 positive cells, causes cell-cycle arrest. more prominent line lacks expression, including higher decrease viability, reduction colony formation, significant remodeling structure. led downregulation functional analysis, showed anti-proliferative lines not based activity stemness marker SOX2, pointing SOX2-independent mechanism action. The ability reduce SOX2/SOX18 raises possibility can be used biomarkers distinguish RA-responders from non-responders. Together, our study shows response may vary, highlighting development RA-based should consider differences subtypes.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest.

Cellular retinoic acid-binding protein II (CRABP-II) is an intracellular lipid-binding protein that associates with retinoic acid with a subnanomolar affinity. We previously showed that CRABP-II enhances the transcriptional activity of the nuclear receptor with which it shares a common ligand, namely, the retinoic acid receptor (RAR), and we suggested that it may act by delivering retinoic acid...

متن کامل

Analysis of Promyelocytic Leukemia in Human Embryonic Carcinoma Stem Cells During Retinoic Acid-Induced Neural Differentiation

Background: Promyelocytic leukemia protein (PML) is a tumor suppressor protein that is involved in myeloid cell differentiation in response to retinoic acid (RA). In addition, RA acts as a natural morphogen in neural development. Objectives: This study aimed to examine PML gene expression in different stages of in vitro neural differentiation of NT2 cells, and to investigate the possible role o...

متن کامل

Receptor and Cellular Retinoic Acid Acid: Proapoptotic Genes Are Targets for Retinoic Acid Suppression of Mammary Carcinoma Growth by Retinoic

Retinoic acid (RA) displays pronounced anticarcinogenic activities in several types of cancer. Whereas the mechanisms that underlie this activity remain incompletely understood, tumor suppression by RA is believed to emanate primarily from its ability to regulate transcription of multiple target genes. Here, we investigated molecular events through which RA inhibits the growth of MCF-7 mammary ...

متن کامل

Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells.

The expression of the retinoic acid receptor beta (RAR beta) mRNA is absent or down-regulated in most human breast cancer cell lines. To investigate the role RAR beta may have in regulating the proliferation of breast cancer cells, we used retroviral vector-mediated gene transduction to introduce the human RAR beta gene into two RAR beta-negative breast tumor cell lines, MCF-7 and MDA-MB-231. R...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Biocell

سال: 2021

ISSN: ['0327-9545', '1667-5746']

DOI: https://doi.org/10.32604/biocell.2021.015817